|
Konu Bal: ATLTV1102, %54.4 etkili... Gnderen: KoraY zerinde 10 Temmuz 2008 - 14:50:58 Relapsing-remitting hastalari icin ATL/TV1102 adindaki anti-sense(hissettirmeyen) ilacinin, yeni lezyon olusumunda Placeboya gore %54.4 azaltici oldugu aciklandi.
3. devre calismalarina gecilmeden once ek olarak klinik arastirmalarin yapilmasi dusunuluyor. ATL/TV1102, igne olarak kullanilacak. Ayrica astim hastalari icinde bu ilacla bazi calismalar yapiliyor. ATL/TV1102 ilacinin lisansi Teva sirketine ait... (30 Haziran 2008) ATL/TV1102 reduces disease activity in multiple sclerosis patients Teva Pharmaceutical Industries Ltd. and Antisense Therapeutics Ltd. announced that anti-sense drug, ATL/TV1102, significantly reduced disease activity in patients with relapsing-remitting multiple sclerosis. The companies noted that their Phase IIa study met its primary endpoint showing a significant reduction by 54.4% in cumulative number of new active lesions in patients taking ATL/TV1102, compared to placebo. In general, ATL/TV1102 was well tolerated. Based on these encouraging results, Teva said it intends to conduct additional pre-clinical and clinical research before continuing to a Phase III study with ATL/TV1102. Antisense Therapeutics has two drugs in development and two drugs in pre-clinical research. ATL/TV1102 (injection) is in the advanced stages of a Phase IIa trial as a potential treatment of multiple sclerosis. ATL/TV1102 (inhaled) is at the pre-clinical research stage as a potential treatment for asthma. ATL/TV1102 has been licensed to Teva. Teva is responsible for funding and performing future development activities for ATL/TV1102. Teva's decision to move forward with the development of ATL/TV1102 will earn a US$4 million milestone payment under the license agreement between Teva and Antisense Therapeutics. Source: RTTNews © 2008 RTTNews (30/06/08) Konu Bal: Ynt: ATLTV1102, %54.4 etkili... Gnderen: aysn.dvn zerinde 11 Temmuz 2008 - 14:52:26 Saðolasýn koray bilgilendirdiðin için.Teþekkürler... Konu Bal: Ynt: ATLTV1102, %54.4 etkili... Gnderen: KoraY zerinde 11 Temmuz 2008 - 16:05:25 yazilarimi takip ettigin icin bende tesekkur ederim Hazan ;)
Konu Bal: Ynt: ATLTV1102, %54.4 etkili... Gnderen: oslem zerinde 11 Temmuz 2008 - 19:04:16 Yazýlarýný, verdiðin bilgileri takip etmemek mümkün mü Koray:) teþekkürler
Konu Bal: Ynt: ATLTV1102, %54.4 etkili... Gnderen: aysn.dvn zerinde 11 Temmuz 2008 - 22:49:52 Valla koray özellikle yeni çalýþmalarý not alýyorum inan ki.Ýnþallah birgün hepimiz þifa bulacaðýz.
Ben teþekkür ederim arkadaþým.Saðlýk ve sevgiyle kalýnýz daima.. Konu Bal: Ynt: ATLTV1102, %54.4 etkili... Gnderen: orhan0012 zerinde 15 Temmuz 2008 - 14:18:56 verdiðiniz bilgiler için hepinize teþekkür etmek istiyorum.bende ms hastasýyým pek nadir giriyorum aslýnda ama yinede sizin gibi arkadaþlarýn bunu takip edip bizlere bildirmesi çok güzel.herþey güzel de keþke iðne yerine hap olarak çýksaydý tek sorunum bu aslýnda.iðneden korkuyorumda 4 yýldýr rebiff kullanýyorum inanýn býktým.zaten artýk kafama göre haftada bazen 2 bazende bir kere vuruyorum.inþallah biþey olmaz bana.
hepiniz kalýn saðlýcakla. orhan........... |